Ignite Creation Date:
2025-12-24 @ 12:19 PM
Ignite Modification Date:
2026-01-30 @ 11:31 PM
Study NCT ID:
NCT06923761
Status:
RECRUITING
Last Update Posted:
2025-11-21
First Post:
2025-03-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EMITT-1 (ERAP Mediated Immunopeptidome Targeting Trial - 1)
Sponsor:
Grey Wolf Therapeutics
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Solid Malignancy | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Oncology | View |
| None | ERAP 1 | View |
| None | Solid tumors | View |
| None | TMB-H | View |
| None | NSCLC | View |
| None | Lung cancer | View |
| None | Cervical cancer | View |
| None | HCC - Hepatocellular Carcinoma | View |
| None | Liver cancer | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | SCCHN | View |
| None | Urothelial cancer | View |
| None | immuno oncology | View |